Cosmos Health Inc. (COSM) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does Cosmos Health Inc. Do?
Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products through its distribution channels and e-commerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece, and the United Kingdom; and warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. The company was formerly known as Prime Estates and Developments, Inc. and changed its name to Cosmos Holdings Inc. in November 2013. Cosmos Holdings Inc. was incorporated in 2009 and is based in Chicago, Illinois. Cosmos Health Inc. (COSM) is classified as a micro-cap stock in the Consumer Staples sector, specifically within the Wholesale industry. The company is led by CEO Grigorios Siokas and employs approximately 100 people. With a market capitalization of $12M, COSM is one of the notable companies in the Consumer Staples sector.
Cosmos Health Inc. (COSM) Stock Rating — Avoid (April 2026)
As of April 2026, Cosmos Health Inc. receives a Avoid rating with a composite score of 26.5/100 and 1 out of 5 stars from the Blank Capital Research quantitative model.COSM ranks #4,066 out of 4,446 stocks in our coverage universe. Within the Consumer Staples sector, Cosmos Health Inc. ranks #167 of 180 stocks, placing it in the lower half of its Consumer Staples peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
COSM Stock Price and 52-Week Range
Cosmos Health Inc. (COSM) currently trades at $0.31. The stock gained $0.02 (6.9%) in the most recent trading session. The 52-week high for COSM is $1.32, which means the stock is currently trading -76.5% from its annual peak. The 52-week low is $0.28, putting the stock 10.7% above its annual trough. Recent trading volume was 794K shares, suggesting relatively thin trading activity.
Is COSM Overvalued or Undervalued? — Valuation Analysis
Cosmos Health Inc. (COSM) carries a value factor score of 22/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 0.48x, versus the sector average of 1.74x. The price-to-sales ratio is 0.19x, compared to 0.35x for the average Consumer Staples stock.
At current multiples, Cosmos Health Inc. trades at a premium to most Consumer Staples peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.
Cosmos Health Inc. Profitability — ROE, Margins, and Quality Score
Cosmos Health Inc. (COSM) earns a quality factor score of 29/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -48.3%, compared to the Consumer Staples sector average of 7.7%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -16.1% versus the sector average of 3.1%.
On a margin basis, Cosmos Health Inc. reports gross margins of 11.9%, compared to 26.2% for the sector. The operating margin is -13.2% (sector: 2.9%). Net profit margin stands at -18.5%, versus 1.6% for the average Consumer Staples stock. Revenue growth is running at 29.6% on a trailing basis, compared to 3.1% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.
COSM Debt, Balance Sheet, and Financial Health
Cosmos Health Inc. has a debt-to-equity ratio of 23.0%, compared to the Consumer Staples sector average of 72.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 0.99x, which may signal near-term liquidity tightness. Total debt on the balance sheet is $5M. Cash and equivalents stand at $889,441.
COSM has a beta of 1.24, meaning it is more volatile than the broader market — a $10,000 investment in COSM would be expected to move 24.1% more than the S&P 500 on any given day. The stability factor score for Cosmos Health Inc. is 25/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.
Cosmos Health Inc. Revenue and Earnings History — Quarterly Trend
In TTM 2026, Cosmos Health Inc. reported revenue of $58M and earnings per share (EPS) of $-0.17. Net income for the quarter was $-11M. Gross margin was 11.9%. Operating income came in at $-8M.
In Q3 2025, Cosmos Health Inc. reported revenue of $17M and earnings per share (EPS) of $-0.17. Net income for the quarter was $-5M. Gross margin was 15.2%. Revenue grew 37.9% year-over-year compared to Q3 2024. Operating income came in at $-2M.
In Q2 2025, Cosmos Health Inc. reported revenue of $15M and earnings per share (EPS) of $-0.10. Net income for the quarter was $-3M. Gross margin was 7.9%. Revenue grew 11.7% year-over-year compared to Q2 2024. Operating income came in at $-3M.
In Q1 2025, Cosmos Health Inc. reported revenue of $14M and earnings per share (EPS) of $-0.03. Net income for the quarter was $-818,097. Gross margin was 14.9%. Revenue grew -6.0% year-over-year compared to Q1 2024. Operating income came in at $-833,145.
Over the past 8 quarters, Cosmos Health Inc. has demonstrated a growth trajectory, with revenue expanding from $15M to $58M. Investors analyzing COSM stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
COSM Dividend Yield and Income Analysis
Cosmos Health Inc. (COSM) does not currently pay a dividend. This is common among smaller companies in the Wholesale industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Consumer Staples dividend stocks may want to explore other Consumer Staples stocks or use the stock screener to filter by dividend yield.
COSM Momentum and Technical Analysis Profile
Cosmos Health Inc. (COSM) has a momentum factor score of 18/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 24/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 53/100 reflects moderate short selling activity.
COSM vs Competitors — Consumer Staples Sector Ranking and Peer Comparison
Within the Consumer Staples sector, Cosmos Health Inc. (COSM) ranks #167 out of 180 stocks based on the Blank Capital composite score. This places COSM in the lower half of all Consumer Staples stocks in our coverage universe. Key competitors and sector peers include Ituran Location & Control Ltd. (ITRN) with a score of 60.3/100, DARLING INGREDIENTS INC. (DAR) with a score of 52.9/100, Bunge Global SA (BG) with a score of 53.0/100, SANFILIPPO JOHN B & SON INC (JBSS) with a score of 54.1/100, and Archer-Daniels-Midland Co (ADM) with a score of 52.2/100.
Comparing COSM against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full COSM vs S&P 500 (SPY) comparison to assess how Cosmos Health Inc. stacks up against the broader market across all factor dimensions.
COSM Next Earnings Date
No upcoming earnings date has been announced for Cosmos Health Inc. (COSM) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy COSM? — Investment Thesis Summary
The quantitative profile for Cosmos Health Inc. suggests caution. The quality score of 29/100 flags below-average profitability. The value score of 22/100 indicates premium valuation. Momentum is weak at 18/100, a headwind for near-term performance. High volatility (stability score 25/100) increases portfolio risk.
In summary, Cosmos Health Inc. (COSM) earns a Avoid rating with a composite score of 26.5/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on COSM stock.
Related Resources for COSM Investors
Explore more research and tools: COSM vs S&P 500 comparison, top Consumer Staples stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare COSM head-to-head with peers: COSM vs ITRN, COSM vs DAR, COSM vs BG.